SETD6 dominant negative mutation in familial colorectal cancer type X

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Human Molecular Genetics

• Publication date

  2017-11-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/hmg/ddx336PMID 28973356
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SETD6 regulates NF-κB signaling in urothelial cell survival: Implications for bladder cancer

  2017cited by this paper
• PAK4 Methylation by SETD6 Promotes the Activation of the Wnt/ (cid:2) -Catenin Pathway *

  2016influential reference
• SETD6 is a negative regulator of oxidative stress response.

  2016cited by this paper
• Proteomic analysis of SETD6 interacting proteins

  2016cited by this paper
• Sequence Variant Descriptions: HGVS Nomenclature and Mutalyzer

  2016cited by this paper
• PAK4 Methylation by SETD6 Promotes the Activation of the Wnt/β-Catenin Pathway*

  2016cited by this paper
• Critical roles of non-histone protein lysine methylation in human tumorigenesis

  2015cited by this paper
• BRCA2 gene: a candidate for clinical testing in familial colorectal cancer type X

  2015cited by this paper
• Analysis of protein-coding genetic variation in 60,706 humans

  2015cited by this paper
• Germline Mutations in FAN1 Cause Hereditary Colorectal Cancer by Impairing DNA Repair.

  2015cited by this paper
• Ensembl 2016

  2015cited by this paper
• Cancer Incidence in Five Continents: Inclusion criteria, highlights from Volume X and the global status of cancer registration

  2015cited by this paper
• Familial colorectal cancer type X: genetic profiles and phenotypic features

  2015cited by this paper
• The European Cancer Observatory: A new data resource.

  2015cited by this paper
• SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information

  2014cited by this paper
• An evaluation of nuclear factor kappa B expression in colorectal carcinoma: an analysis of 50 cases.

  2014cited by this paper
• SMYD2-dependent HSP90 methylation promotes cancer cell proliferation by regulating the chaperone complex formation.

  2014cited by this paper
• PERSPECTIVES IN CLINICAL GASTROENTEROLOGY AND HEPATOLOGY Familial Colorectal Cancer, Beyond Lynch Syndrome

  2014cited by this paper
• Reconstitution of CPSF active in polyadenylation: recognition of the polyadenylation signal by WDR33

  2014cited by this paper
• MutationTaster2: mutation prediction for the deep-sequencing age

  2014cited by this paper
• Lysine methylation-dependent binding of 53BP1 to the pRb tumor suppressor

  2014cited by this paper
• SETD6 controls the expression of estrogen-responsive genes and proliferation of breast carcinoma cells

  2014cited by this paper
• Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer

  2014cited by this paper
• Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas

  2013cited by this paper
• Distinct Gene Expression Signatures in Lynch Syndrome and Familial Colorectal Cancer Type X

  2013cited by this paper
• The complexity of NF-κB signaling in inflammation and cancer

  2013cited by this paper
• Cancer risk and overall survival in mismatch repair proficient hereditary non-polyposis colorectal cancer, Lynch syndrome and sporadic colorectal cancer

  2013cited by this paper
• SETD6 monomethylates H2AZ on lysine 7 and is required for the maintenance of embryonic stem cell self-renewal

  2013cited by this paper
• Gain of chromosomal region 20q and loss of 18 discriminates between Lynch syndrome and familial colorectal cancer.

  2013cited by this paper
• Histone methylation: a dynamic mark in health, disease and inheritance

  2012cited by this paper
• Lysine methylation: beyond histones.

  2012cited by this paper
• Lysine methylation and the regulation of p53.

  2012cited by this paper
• Post-translational modifications of lysine in DNA-damage repair.

  2012cited by this paper
• Role of the SMYD3 histone methyltransferase in tumorigenesis

  2012cited by this paper
• Germline mutations in the proof-reading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas

  2012cited by this paper
• Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration

  2012cited by this paper
• Primer3—new capabilities and interfaces

  2012cited by this paper
• NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming.

  2011cited by this paper
• Analysis of the Oxidative Damage Repair Genes NUDT1, OGG1, and MUTYH in Patients from Mismatch Repair Proficient HNPCC Families (MSS-HNPCC)

  2011cited by this paper
• Lynch Syndrome-Associated Extracolonic Tumors Are Rare in Two Extended Families With the Same EPCAM Deletion

  2011cited by this paper
• A method and server for predicting damaging missense mutations

  2010cited by this paper
• L3MBTL1 polycomb protein, a candidate tumor suppressor in del(20q12) myeloid disorders, is essential for genome stability

  2010cited by this paper
• SETD6 lysine methylation of RelA couples GLP activity at chromatin to tonic repression of NF-κB signaling

  2010cited by this paper
• The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.

  2010cited by this paper
• Setting and resetting of epigenetic marks in malignant transformation and development

  2010cited by this paper
• The activating mutation R201C in GNAS promotes intestinal tumourigenesis in ApcMin/+ mice via activation of Wnt and ERK1/2 MAPK pathways

  2010cited by this paper
• Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm

  2009cited by this paper
• CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells.

  2009cited by this paper
• The Human Gene Mutation Database: 2008 update

  2009cited by this paper
• CCDC 62 / ERAP 75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells

  2009cited by this paper
• VarScan: variant detection in massively parallel sequencing of individual and pooled samples

  2009cited by this paper
• Human Splicing Finder: an online bioinformatics tool to predict splicing signals

  2009cited by this paper
• The Sequence Alignment/Map format and SAMtools

  2009cited by this paper
• The emerging field of dynamic lysine methylation of non-histone proteins.

  2008cited by this paper
• Modulation of p53 function by SET8-mediated methylation at lysine 382.

  2007cited by this paper
• Chromatin modifications and their function.

  2007cited by this paper
• Molecular Analysis of Colorectal Cancer Tumors from Patients with Mismatch Repair–Proficient Hereditary Nonpolyposis Colorectal Cancer Suggests Novel Carcinogenic Pathways

  2007cited by this paper
• Dynamic regulation of histone lysine methylation by demethylases.

  2007cited by this paper
• Oncogenic re-wiring of cellular signaling pathways

  2007cited by this paper
• Dual role of LOH at MMR loci in hereditary non-polyposis colorectal cancer?

  2006cited by this paper
• Protocol for the fast chromatin immunoprecipitation (ChIP) method

  2006cited by this paper
• Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.

  2005cited by this paper
• Comprehensive characterization of HNPCC-related colorectal cancers reveals striking molecular features in families with no germline mismatch repair gene mutations

  2005cited by this paper
• Histone modifying enzymes and cancer: Going beyond histones

  2005cited by this paper
• Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters

  2004cited by this paper
• Histones and histone modifications.

  2004cited by this paper
• Genetic testing for high-risk colon cancer patients.

  2003cited by this paper
• Mechanism of multiple lysine methylation by the SET domain enzyme Rubisco LSMT

  2003cited by this paper
• Gene expression differences between the microsatellite instability (MIN) and chromosomal instability (CIN) phenotypes in colorectal cancer revealed by high-density cDNA array hybridization

  2002cited by this paper
• MSH6 and MSH3 are rarely involved in genetic predisposition to nonpolypotic colon cancer.

  2001cited by this paper
• APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits".

  2000cited by this paper
• Chromatin Association of Human Origin Recognition Complex, Cdc6, and Minichromosome Maintenance Proteins during the Cell Cycle: Assembly of Prereplication Complexes in Late Mitosis

  2000cited by this paper
• Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.

  2000cited by this paper
• dbSNP: a database of single nucleotide polymorphisms

  2000cited by this paper
• Genetic susceptibility to non-polyposis colorectal cancer

  1999cited by this paper
• New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

  1999cited by this paper
• Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC

  1997cited by this paper
• Extracolonic cancer in hereditary nonpolyposis colorectal cancer

  1993cited by this paper
• The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)

  1991influential reference
• Chromatin Modifications and Their Function

  year unknowncited by this paper

• Lynch Syndrome in Focus: A Multidisciplinary Review of Cancer Risk, Clinical Management, and Special Populations

  2025cites this paper
• SETD6 mediates selective interaction and genomic occupancy of BRD4 and MITF in melanoma cells

  2025cites this paper
• Hereditary Colorectal Cancer: Clinical Implications of Genomic Medicine and Precision Oncology

  2025cites this paper
• Orchestrating epigenetics: a comprehensive review of the methyltransferase SETD6

  2025influential citation
• Predicting patient outcomes with gene-expression biomarkers from colorectal cancer organoids and cell lines

  2025cites this paper
• Risk for Hereditary Neoplastic Syndromes in Women with Mismatch Repair-Proficient Endometrial Cancer

  2023cites this paper
• Methylation of the transcription factor E2F1 by SETD6 regulates SETD6 expression via a positive feedback mechanism

  2023cites this paper
• E2F1 methylation by SETD6 regulates SETD6 expression via positive feedback mechanism

  2023cites this paper
• New insights on familial colorectal cancer type X syndrome

  2022cites this paper
• Exome hits demystified: The next frontier.

  2021cites this paper
• Silencing of SETD6 inhibits the tumorigenesis of oral squamous cell carcinoma by inhibiting methylation of PAK4 and RelA.

  2021cites this paper
• PAK4 methylation by the methyltransferase SETD6 attenuates cell adhesion

  2020cites this paper
• A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer

  2020cites this paper
• Dominantly Inherited Hereditary Nonpolyposis Colorectal Cancer Not Caused by MMR Genes

  2020cites this paper
• Germline mutational profile of Chinese patients under 70 years old with colorectal cancer

  2020cites this paper
• BRIP1, a Gene Potentially Implicated in Familial Colorectal Cancer Type X

  2020cites this paper
• Candidate Gene Discovery in Hereditary Colorectal Cancer and Polyposis Syndromes–Considerations for Future Studies

  2020cites this paper
• Approaches to functionally validate candidate genetic variants involved in colorectal cancer predisposition.

  2019cites this paper
• Update on genetic predisposition to colorectal cancer and polyposis.

  2019cites this paper
• Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicine

  2019cites this paper
• The missing heritability of familial colorectal cancer

  2019cites this paper
• Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials

  2019cites this paper
• Bacterial DNA induces the formation of heat-resistant disease-associated proteins in human plasma

  2019cites this paper
• Oligomerization and Auto-methylation of the Human Lysine Methyltransferase SETD6.

  2018cites this paper
• Enhanced PKMT-substrate recognition through non active-site interactions.

  2018cites this paper
• Elsevie and n of the Human nsferase SETD 6

  2018cites this paper
• Risks of Colorectal Cancer and Cancer-Related Mortality in Familial Colorectal Cancer Type X and Lynch Syndrome Families.

  2018cites this paper
• Hereditary Nonpolyposis Colorectal Cancer and Cancer Syndromes: Recent Basic and Clinical Discoveries

  2018cites this paper